ENTRY       D02729                      Drug
NAME        Itopride hydrochloride (JAN);
            Ganaton (TN)
FORMULA     C20H26N2O4. HCl
EXACT_MASS  394.1659
MOL_WEIGHT  394.8924
CLASS       Neuropsychiatric agent
             DG01595  Cholinesterase inhibitor
              DG01593  Acetylcholinesterase inhibitor
              DG01594  Butyrylcholinesterase inhibitor
            Gastrointestinal agent
             DG01763  Propulsive
            Metabolizing enzyme substrate
             DG03191  FMO1 substrate
             DG02950  FMO3 substrate
REMARK      Therapeutic category: 2399
            ATC code: A03FA07
            Chemical structure group: DG01395
            Product (DG01395): D02729<JP>
EFFICACY    Prokinetic, Dopamine receptor antagonist
COMMENT     Benzamide derivative
TARGET      DRD2 [HSA:1813] [KO:K04145]
            ACHE [HSA:43] [KO:K01049]
  PATHWAY   hsa04080(1813)  Neuroactive ligand-receptor interaction
            hsa04725(43)  Cholinergic synapse
            hsa04728(1813)  Dopaminergic synapse
METABOLISM  Enzyme: FMO1 [HSA:2326], FMO3 [HSA:2328]
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             A ALIMENTARY TRACT AND METABOLISM
              A03 DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS
               A03F PROPULSIVES
                A03FA Propulsives
                 A03FA07 Itopride
                  D02729  Itopride hydrochloride (JAN) &lt;JP&gt;
            Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              23  Digestive organ agents
               239  Miscellaneous
                2399  Others
                 D02729  Itopride hydrochloride (JAN)
            Risk category of Japanese OTC drugs [BR:br08312]
             Drugs requiring guidance
              New approved switch OTC drugs
               Itopride hydrochloride
                D02729  Itopride hydrochloride (JAN)
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG01595  Cholinesterase inhibitor
               DG01593  Acetylcholinesterase inhibitor
                DG01395  Itopride
                 D02729  Itopride hydrochloride
               DG01594  Butyrylcholinesterase inhibitor
                DG01395  Itopride
                 D02729  Itopride hydrochloride
             Gastrointestinal agent
              DG01763  Propulsive
               DG01395  Itopride
                D02729  Itopride hydrochloride
             Metabolizing enzyme substrate
              DG03191  FMO1 substrate
               DG01395  Itopride
                D02729  Itopride hydrochloride
              DG02950  FMO3 substrate
               DG01395  Itopride
                D02729  Itopride hydrochloride
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Dopamine
                DRD2
                 D02729  Itopride hydrochloride (JAN) &lt;JP&gt;
             Enzymes
              Hydrolases (EC3)
               Carboxylic-ester hydrolases
                ACHE
                 D02729  Itopride hydrochloride (JAN) &lt;JP&gt;
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D02729
            Rx-to-OTC switch list in Japan [br08314.html]
             D02729
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG01595  Cholinesterase inhibitor
               DG01593  Acetylcholinesterase inhibitor
                DG01395  Itopride
               DG01594  Butyrylcholinesterase inhibitor
                DG01395  Itopride
             Gastrointestinal agent
              DG01763  Propulsive
               DG01395  Itopride
             Metabolizing enzyme substrate
              DG03191  FMO1 substrate
               DG01395  Itopride
              DG02950  FMO3 substrate
               DG01395  Itopride
DBLINKS     CAS: 122892-31-3
            PubChem: 17396896
            LigandBox: D02729
            NIKKAJI: J557.524I
ATOM        27
            1   C8y C    14.4200  -16.2400
            2   C8x C    14.4200  -14.8400
            3   C8x C    13.1600  -16.9400
            4   C5a C    15.6800  -16.9400
            5   C8x C    13.1600  -14.1400
            6   C8y C    11.9700  -16.2400
            7   N1b N    16.8700  -16.2400
            8   O5a O    15.6800  -18.3400
            9   C8y C    11.9700  -14.8400
            10  O2a O    10.7800  -16.9400
            11  C1b C    18.1300  -16.9400
            12  O2a O    10.7800  -14.1400
            13  C8y C    19.3200  -16.2400
            14  C1a C     9.5200  -14.8400
            15  C1a C     9.5200  -16.3100
            16  C8x C    20.5100  -16.9400
            17  C8x C    21.7000  -16.2400
            18  C8y C    21.7000  -14.8400
            19  C8x C    20.5100  -14.1400
            20  C8x C    19.3200  -14.8400
            21  O2a O    22.9600  -14.1400
            22  C1b C    24.1500  -14.8400
            23  C1b C    25.3400  -14.1400
            24  N1c N    26.6000  -14.8400
            25  C1a C    27.7900  -14.1400
            26  C1a C    26.6000  -16.2400
            27  X   Cl   24.5700  -18.8300
BOND        27
            1     1   2 1
            2     1   3 2
            3     1   4 1
            4     2   5 2
            5     3   6 1
            6     4   7 1
            7     4   8 2
            8     5   9 1
            9     6  10 1
            10    7  11 1
            11    9  12 1
            12   11  13 1
            13    6   9 2
            14   12  14 1
            15   10  15 1
            16   13  16 2
            17   16  17 1
            18   17  18 2
            19   18  19 1
            20   19  20 2
            21   13  20 1
            22   18  21 1
            23   21  22 1
            24   22  23 1
            25   23  24 1
            26   24  25 1
            27   24  26 1
///
